Procter & Gamble Health Limited (PGHL) announced that its Board of Directors, in a meeting held on February 6, 2026, declared an interim dividend of ₹160 per equity share. This includes a one-time special dividend of ₹50 per share. The interim dividend, subject to member approval, will be paid to shareholders whose names appear in the company's register of members or as beneficial owners in the depositories' records as of the close of business hours on February 12, 2026. This date has been set as the record date. The announcement also provides detailed guidance on Tax Deducted at Source (TDS) for both resident and non-resident shareholders, outlining applicable rates, required documentation, and procedures for updating tax information. Shareholders are urged to provide necessary details to the company's registrar and share transfer agent, M/s. Kfin Technologies Private Limited, or their respective depositories by February 10, 2026, to ensure correct TDS deduction.
